Navigation Links
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Fourth Quarter and Full Year Financial Results
Date:2/23/2010

he high dose of LX1031 produced statistically-significant improvements in a global assessment of relief of IBS pain and discomfort and in stool consistency as compared to placebo — clinical benefits that correspond with a reduction in serotonin synthesis.
  • Lexicon completed Phase 2a studies of its drug candidate for type 2 diabetes, LX4211, an inhibitor of sodium-glucose cotransporter 2 (SGLT2).  Top-line data from the Phase 2a trial, reported in January 2010, showed statistically-significant and rapid improvements in multiple parameters in patients with type 2 diabetes, including improved glycemic control and reduced HbA1c within four weeks. In addition, reductions in weight, blood pressure, and triglyceride levels were observed for both treatment arms relative to placebo.
  • Lexicon advanced LX2931, an inhibitor of sphingosine-1-phosphate (S1P) lyase, into a Phase 2a study in patients with rheumatoid arthriti
    '/>"/>

  • SOURCE Lexicon Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related biology technology :

    1. Lexicon Announces Proposed Offering of 27,500,000 Shares of Common Stock
    2. Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
    3. Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on July 28, 2009
    4. Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome
    5. Lexicon Names Ajay Bansal Executive Vice President and Chief Financial Officer
    6. Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week
    7. Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2009 Financial Results on April 28, 2009
    8. Lexicon Pharmaceuticals 2008 Annual Report to Stockholders Available Online
    9. Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals
    10. Lexicon to Report Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008
    11. Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2015)... India , August 28, 2015 ... by Product (Media, Sera, Cryogenic Storage Systems, Thawing Equipment, ... (Therapeutic, Regenerative Medicine, Clinical Trials), End User - Global ... Market is expected to reach USD 3,731.03 Million by ... a CAGR of 11.65% between 2015 and 2020. ...
    (Date:8/28/2015)... ... 2015 , ... Since the initial launch of FireflySci Inc. (FFS) in early 2015, the company ... Images such as the Fonz in a lab coat and Large Marge have been ... spectroscopy field. , FireflySci is proud to be the only cuvette manufacturer is ...
    (Date:8/27/2015)... , Aug. 27, 2015 The ... a patient,s eyes—and life—were saved by doctors at Vanderbilt ... working with NNFF, NovaBay Pharmaceuticals and Dr. John ... Center at Seton Medical Center in ... treatment used a breakthrough approach, pioneered by Dr. Crew, ...
    (Date:8/27/2015)... ... August 27, 2015 , ... Inc. Magazine released its annual list of the ... 1,361 in growth for the three years through 2014. Being named to the Inc. ... organizations in the country. , “We are thrilled to make the Inc. 5000 ...
    Breaking Biology Technology:Biopreservation Market Worth 3,731.03 Million USD by 2020 2Biopreservation Market Worth 3,731.03 Million USD by 2020 3Biopreservation Market Worth 3,731.03 Million USD by 2020 4Biopreservation Market Worth 3,731.03 Million USD by 2020 5Cuvette Manufacturer FireflySci Launches Back to School Deals with Complimentary Shipping On All Orders 2Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 2Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 3iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3
    ... PALO ALTO and SANTA ROSA, Calif., Feb. 4 ... Medlogics Device Corporation,announced today that the companies have ... CV Therapeutics, proprietary biopolymer stent,coating technology to develop ... stock and is entitled to development milestone payments,royalties ...
    ... Feb. 4 /Xinhua-PRNewswire-FirstCall/ --,(OTC Bulletin Board: KWBT) Kiwa ... Wei Li, met to discuss cooperative ventures with,members ... Inc. of,Ottawa (Toronto Venture Exchange Symbol: SXS)., ... Li was Dr. Jianqiang,Zhou who is the Chief ...
    ... (NYSE: WYE ),announced today that it will ... and Medical Device Conference on Thursday,February 7, 2008 ... will be,Geno Germano, President, U.S. Pharmaceuticals & Women,s ... webcast live for investors at, http://www.wyeth.com and ...
    Cached Biology Technology:CV Therapeutics and Medlogics Device Corporation Sign Licensing Agreement for CVT's Innovative Stent Coating Technology 2CV Therapeutics and Medlogics Device Corporation Sign Licensing Agreement for CVT's Innovative Stent Coating Technology 3Kiwa Bio-Tech Products Group Discusses Cooperative Efforts With Canadian Agricultural Ministry and Canadian Company 2Kiwa Bio-Tech Products Group Discusses Cooperative Efforts With Canadian Agricultural Ministry and Canadian Company 3Wyeth to Present at the Merrill Lynch 2008 Global Pharmaceutical, Biotechnology and Medical Device Conference 2
    (Date:8/5/2015)... The biosensors market is proving highly attractive ... newer sectors, and development of devices resulting in higher ... seen the entry of multiple participants each year with ... (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) Recent ... Global Biosensors Market ( http://www.frost.com/nee9 ), finds that ...
    (Date:8/4/2015)... AMRI ) today reported financial and operating results for the second ... Second quarter contract revenue of $ 85.2 million, ... margins of 26 % , Second quarter ... from royalties in the current quarter , Operating ... pleased to present another strong financial quarter, with all our divisions ...
    (Date:7/31/2015)... SHENZHEN , Kina, 31. juli 2015 ... ) bliver afholdt af BGI fra den 22. - 25. ... Konferencen fejrer sin 10-års fødselsdag i år. ... verdens mest indflydelsesrige årlige møder på ,omik,-feltet, og er ... forsamlinger. ICG-10 fokuserer på nylige gennembrud ...
    Breaking Biology News(10 mins):Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2
    ... 23, 2007, President Bush stated that, in order to substantially ... alternative fuels, by setting a mandatory fuels standard to require ... This mandate coupled with a $1.01 ethanol refiner ... subsidy per ton of biomass production for growers are putting ...
    ... beliefs about inconclusive DNA testing for hereditary breast cancer ... an especially strong predictor of whether women had been ... a study in the October issue of Genetics ... of Medical Genetics (ACMG). The journal is published ...
    ... rely on friends to help get what they need and, ... the University of Wisconsin-Madison, many microbes, plants and animals benefit ... was funded by the National Science Foundation (NSF) and published ... Science , describes the complex relationship between a beetle, two ...
    Cached Biology News:Mandate for biofuels production requires science-based policy and global perspective 2Study looks at psychological impact of gene test for breast cancer 2Study looks at psychological impact of gene test for breast cancer 3Beetles get by with a little help from their friends 2
    ... Array (MSTA) slides were designed to study protein ... multiple species. Tissue slices from three different ... can then be treated as a single histological ... situ hybridization. This format allows a ...
    ... MacMelt software is used on ... melting profile of any DNA sequence ... in optimizing placement of primers and ... denaturing gradient gel electrophoresis (DGGE), constant ...
    ... To score SNPs, Polymorphic uses proven, validated ... in DNA analysis. We use high throughput ... be confirmed by sequencing in both directions. ... sequence context information, further confirming the location ...
    ... Model 192 and PowerPac basic power supply are ... acids in agarose gels. This Model 192 cell ... cm UV-transparent gel tray with fluorescent ruler, and ... 100-120 and 220-240 V, provides output of 10-300 ...
    Biology Products: